切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2016, Vol. 10 ›› Issue (03) : 265 -268. doi: 10.3877/cma.j.issn.1674-1358.2016.03.003

综述

慢性乙型肝炎母婴传播的影响因素新进展
杨敏1, 刘映霞2,()   
  1. 1. 518112 深圳市,南华大学深圳市第三人民医院感染科
    2. 518112 深圳市,传染病学国家重点学科,深圳市第三人民医院感染科
  • 收稿日期:2015-10-27 出版日期:2016-06-15
  • 通信作者: 刘映霞
  • 基金资助:
    深圳市科技计划项目(No. JCYJ20150402111430629); 深圳市新发传染病重点专科(No. 201161)

New progress of the influence factors of mother-to-child transmission of chronic hepatitis B

Min Yang1, Yingxia Liu2,()   

  1. 1. Department of Infectious Diseases, University of South China Shenzhen Third People’s Hospital, Shenzhen 518112, China
    2. State Key Discipline of Infectious Diseases, Department of Infectious Diseases, Shenzhen Third People’s Hospital, Shenzhen 518112, China
  • Received:2015-10-27 Published:2016-06-15
  • Corresponding author: Yingxia Liu
引用本文:

杨敏, 刘映霞. 慢性乙型肝炎母婴传播的影响因素新进展[J]. 中华实验和临床感染病杂志(电子版), 2016, 10(03): 265-268.

Min Yang, Yingxia Liu. New progress of the influence factors of mother-to-child transmission of chronic hepatitis B[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2016, 10(03): 265-268.

乙型肝炎病毒(HBV)传播的主要途径是母婴传播,对母亲HBsAg阳性的新生儿进行联合免疫(HBIG +乙肝疫苗),母婴阻断成功率可达90%~95%,但对于高病毒载量的母亲,在联合免疫的情况下,仍有8%~32%的婴儿在围生期感染HBV,在围产期感染HBV者有90%发展成慢性感染,这些慢性感染者有15%~25%死于肝硬化和肝癌。因此,对HBV感染的孕妇进行管理及制定阻断HBV母婴传播的策略对降低母婴传播率至关重要。由于人们对此类问题的敏感性,临床试验难以进行。本文将从HBV母婴传播模式和影响因素等方面进行综述。

HBV is mainly transmitted via mother-to-child transmission (MTCT), combined immunization (HBIG + hepatitis B vaccination) had reduced 90%-95% newborns MTCT, but for mothers of high viral load, there were still 8%-32% newborns infected with HBV. Over 90% of perinatally acquired infections progress to chronic HBV infection. There were 15%-25% of these chronic infected people will die of cirrhosis or liver cancer eventually. Therefore, the management of HBsAg-positive pregnant women and the strategy of blocking MTCT are crucial to reduce the MTCT rate. Due to the sensitivity of such problems, clinical trials are difficult. Here, the routes of transmission and influencing factors of MTCT were overviewed.

1
WHO. Hepatitis B Fact Sheets [EB/OL]. 2014.

URL    
2
WHO. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection [EB/OL]. 2015.

URL    
3
乙型肝炎病毒感染女性生育管理专家委员会. 乙型肝炎病毒感染女性生育管理专家共识(指南)[J/CD]. 中华实验和临床感染病杂志:电子版,2014,8(1):92-95.
4
Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus:an Australian experience[J]. Med J Aust,2009,190(9):489-492.
5
Yang YJ, Liu CC, Chen TJ et al. Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigennegative carrier mothers in Taiwan[J]. Pediatr Infect Dis J,2003,22(7):584-588.
6
Xu WN, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent transmission of hepatitis B virus infecton: a multicentre, randomized, double-blind,placebo-controlled study[J]. J Viral Hepat,2009,16(2):94-103.
7
Lai CL, Ratziu V, Yuen MF, et al. Viral hepatitis B[J]. Lancet,2003,362(9401):2089-2094.
8
夏国良,龚健,王继杰, 等. 重组乙型肝炎疫苗阻断乙型肝炎病毒母婴传播方案的保护效果评价[J]. 中华流行病学杂志,2003,24(5):362-365.
9
Yi W, Liu M, Chen A, et al. The efficacy of lamivudine use in the second vs. third trimester of pregnancy in preventing vertical transmission of HBV in highly viremic mothers[J]. Hepatology,2013;58(1):614.
10
中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年版) [J/CD]. 中华实验和临床感染病杂志:电子版,2015,9(5):570-589.
11
Pan C, Liu M, Cai H, et al. Safety of tenofovir disoproxil fumarate (TDF) treatment for the entire pregnancy in mothers with active chronic hepatitis B or cirrhosis[J]. Hepatology,2013,58(1):624.
12
Xu YY, Liu HH, Zhong YW, et al. Peripheral blood mononuclear cell traffic plays a crucial role in mother-to-infant transmission of hepatitis B virus[J]. Int J Biol Sci,2015,11(3):266-273.
13
Lin HH, Ohto H, Etoh T, et al. Studies on the risk factors of intrauterine infection of hepatitis B virus[J]. Nihon Sanka Fujinka Gakkai zasshi,1985,37(11):2393-2400.
14
Ohto H, Lin HH, Kawana T, et al. Intrauterine transmission of hepatitis B virus is closely related to placental leakage[J]. J Med Virol,1987,21(1):1-6.
15
Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus:a case-control study[J]. J Med Virol,2002,67(1):20-26.
16
Bai GQ, Li SH, Yue YF, et al. The study on role of peripheral blood mononuclear cell in HBV intrauterine infection[J]. Arch Gynecol Obstet,2011,283(2):317-321.
17
Murakami Y, Minami M, Daimon Y, et al. Hepatitis B virus DNA in liver,serum,and Peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen[J]. J Med Virol,2004,72(2):203-214.
18
Lu L, Zhang HY, Yueng YH, et al.Intracellular levels of hepatitis B virus DNA and pregenomic RNA in peripheral blood mononuclear cells of chronically infected patients[J]. J Med Virol,2009,16(2):104-112.
19
魏俊妮,王素萍,双杰玉. 母胎转运与乙型肝炎病毒宫内感染关系的研究[J]. 中华流行病学杂志,2005,26(4):240-244.
20
石磊,岳亚飞,张树林, 等. 新生儿外周血单个核细胞感染乙型肝炎病毒的机制及意义[J]. 中华儿科杂志,2006,44(11):855-858.
21
Li XM, Shi MF, Yang YB, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection[J]. World J Gastroenterol,2004,10(21):3215-3217.
22
Xu Q, Xiao L, Lu XB, et al. A randomized controlled clinical trial:interruption of intrauterine transmission of hepatitis B virus infection with HBIG[J]. Word J Gastroenterol,2006,12(21):3434-3437.
23
Shao QL, Zhao XX, Yao L. Role of peripheral blood mononuclear cell transportation from mother to baby in HBV intrauterine infection[J]. Arch Gynecol Obstet,2013,288(6):1257-1261.
24
Ye F, Jin Y, Kong Y, et al.The presence of HBV mRNA in the fertilized in vitro embryo of HBV patients confirms vertical transmission of HBV via the ovum[J]. Epidemiol Infect,2013,141(5):926-930.
25
Yang J, Zeng X, Men Y, et al. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus-a systematic review[J]. Virol J,2008,5(8):100-107.
26
Pol S, Corouge M, Fontaine H. Hepatitis B virus infection and pregnancy[J]. Clin Res Hepatol Gastroenterol,2011,35(10):618-622.
27
Kumar A. Hepatitis B virus infection and pregnancy:apractical approach[J]. Indian J Gastroenterol,2012,31(2):43-54.
28
Pan CQ, Duan ZP, Bhamidimarri KR, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus[J]. Clin Gastroenterol Hepaterol,2012,10(5):452-459.
29
Wong VC, Lee AK, Ip HM. Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant[J]. Br J Obstet Gynaecol,1980,87(11):958-965.
30
Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection[J]. Hepatology,2003,38(5):1075-1086.
31
Thompson AJ, Nguyen T, Iser D, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers[J]. Hepatology,2010,51(6):1933-1944.
32
Deguchi M, Yamashita N, Kagita M, et al. Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay[J]. J Virol Methods,2004,115(2):217-222.
33
Demiroren K, Kocamaz H, Doqan Y. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B[J]. Turk J Gastroenterol,2015,26(1):36-41.
34
Wiseman E, Fraser MA, Holden S, et al. Perinatal transmission of hepatitis B virus:an Australian experience[J]. Med J Aust,2009,190(9):489-92.
35
Zou H, Chen Y, Duan Z, et al. Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers[J]. J Viral Hepat,2012,19(2):18-25..
36
Samadi Kochaksaraei G, Congly SE, Matwiy T, et al. Cost effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk[J]. Liver Int,2016. [Epub ahead of print]
37
Wen WH, Huang CW, Chie WC,et al. Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection[J]. Hepatology,2016. [Epub ahead of print]
38
Pan CQ, Zou HB, Chen Y, et al. Cesarean section reduces perinatal transmission of HBV Infection from hepatitis B surface antigen-positive women to their infants[J]. Clin Gastroenterol Hepatol,2013,11(10):1349-1355.
39
Liu Y, Wang M, Yao S, et al. Efficacy and safety of telbivudine in different trimesters of pregnancy with high viremia for interrupting perinatal transmission of HBV[J]. Hepatol Res,2016,46(3):181-188.
40
Shi Z, Yang Y, Wang H, et al. Breastfeeding of newborns by motherscarrying hepatitis B virus:a meta-analysis and systematicreview[J]. Arch Pediatr Adolesc Med,2011,165(9):837-846.
41
Hill JB, Sheffield JS, Kim MJ, et al. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers[J]. Obstet Gynecol,2002,99(6),1049-1052.
42
Sokal EM, Paganelli M, Wirth S, et al. Management of chronichepatitis B in childhood:ESPGHAN clinical practice guidelines:consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition[J]. J Hepatol,2013,59(4):814-829.
43
Wong VC, Lee AK, Ip HM. Transmission of hepatitis B antigens from symptoms free carrier mothers to the fetus and the infant[J]. Br J Obstet Gynaecol,1980,87(11):958-965.
44
Bzowej NH. Optimal management of the hepatitis B patient who desires pregnancy or is pregnant[J]. Curr Hepatitis Rep,2012,11(2):82-89.
45
Xu YY, Yu JY, Zhong YW, et al. Association between the frequency of class II HLA antigens and the susceptibility to intrauterine infection of hepatitis B virus[J]. Int J Biol Sci,2008,4(2):111-115.
46
Keeffe EB, Dieterich DT, Han SH, et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States:2008 update[J]. Clin Gastroenterol Hepatol,2008,6(12):1315-1341.
47
Yu M, Jiang Q, Gu X, et al. Correlation between vertical transmission of hepatitis B virus and the expression of HBsAg in ovarian follicles and placenta[J]. PLoS One,2013,8(1):54246.
48
Zhang SL, Yue YF, Bai GQ, et al. Mechanism of Intrauterine infection of hepatitis B virus[J]. World J Gastroenterology,2004,10(3):437-438.
49
Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study[J]. J Med Virol,2002,67(1):20-26.
50
Lu LL, Chen BX, Wang J, et al. Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women[J]. Int J Infect Dis,2014,28(7):41-44.
[1] 高建松, 陈晓晓, 冯婷, 包剑锋, 魏淑芳, 潘林. 基于超声瞬时弹性成像的多参数决策树模型评估慢性乙型肝炎患者肝纤维化等级[J]. 中华医学超声杂志(电子版), 2023, 20(09): 923-929.
[2] 刘嘉嘉, 王承华, 陈绪娇, 刘瑗玲, 王善钰, 屈海花, 张莉. 经阴道子宫-输卵管实时三维超声造影中患者疼痛发生情况及其影响因素分析[J]. 中华医学超声杂志(电子版), 2023, 20(09): 959-965.
[3] 高玲, 于哲, 范然, 臧银善. 外周血细胞计数比值评估类风湿关节炎疗效的价值[J]. 中华关节外科杂志(电子版), 2023, 17(05): 642-647.
[4] 王蓓蓓, 董启秀, 郗红燕, 于庆云, 张丽君, 式光. 早孕期孕妇药物流产失败的影响因素分析与构建相关预测模型及其对药物流产成功的预测价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 588-594.
[5] 陈絮, 詹玉茹, 王纯华. 孕妇ABO血型联合甲状腺功能检测对预测妊娠期糖尿病的临床价值[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 604-610.
[6] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[7] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[8] 甄子铂, 刘金虎. 基于列线图模型探究静脉全身麻醉腹腔镜胆囊切除术患者术后肠道功能紊乱的影响因素[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 61-65.
[9] 黄汇, 朱信强. 131I治疗45岁以下分化型甲状腺癌的疗效及影响因素[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 627-630.
[10] 顾娇娇, 邹燕, 陈奕辰, 黄师菊, 张慧玲, 林楠. 基于简易营养评价精法评估肝癌患者出院后营养状况及其影响因素[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 534-539.
[11] 陈淑钿, 梁韵, 廖媛, 王杨. 补体C3在HBV相关慢加急性肝衰竭患者预后评估中的价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 562-566.
[12] 杨静, 顾红叶, 赵莹莹, 孙梦霞, 查园园, 王琪. 老年血液透析患者短期死亡的影响因素及列线图预测模型的预测作用[J]. 中华肾病研究电子杂志, 2023, 12(05): 254-259.
[13] 刘代江, 蒋俊艳, 万晓强, 马莎英. 结直肠癌肝转移患者生存状况及预后影响因素分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(05): 284-288.
[14] 杜振双, 胡清福, 林颖艺, 张月霞, 陈美丽, 李祎祺, 王振华. 社区全科医师激励机制的影响因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 876-883.
[15] 孔凡彪, 杨建荣. 肝脏基础疾病与结直肠癌肝转移之间关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(07): 818-822.
阅读次数
全文


摘要